Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Amlodipine/rosuvastatin/valsartan - Kyung Dong

Next Previous
Search
Drug Profile

Amlodipine/rosuvastatin/valsartan - Kyung Dong

Alternative Names: Amlodipine/valsartan/rosuvastatin - Kyung Dong; KD5001

Latest Information Update: 23 Feb 2022

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Kyung Dong
  • Class Antihyperlipidaemics; Antihypertensives; Branched-chain amino acids; Dihydropyridines; Fluorobenzenes; Ischaemic heart disorder therapies; Pyrimidines; Small molecules; Sulfonamides; Tetrazoles
  • Mechanism of Action Angiotensin type 1 receptor antagonists; Calcium channel antagonists; HMG-CoA reductase inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Discontinued Dyslipidaemias; Hypertension

Most Recent Events

  • 23 Feb 2022 Discontinued - Phase-III for Dyslipidaemias and Hypertension (In the elderly, In adults) in South Korea (PO) (Kyung Dong pipeline, February 2022)
  • 20 Jan 2020 Kyung Dong Pharmaceuticals completes a phase I trial in Hypertension and Dyslipidemia and in South Korea (KCT0003475)
  • 26 Jul 2019 Kyung Dong Pharmaceutical plans a phase I trial for Dyslipidemia (Healthy volunteers) in South Korea (PO) (KCT0004141)

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top